This study is examining a treatment called Transcutaneous Electrical Nerve Stimulation (TENS) for people with early-stage breast cancer who have developed chemotherapy-induced peripheral neuropathy (CIPN). CIPN happens when chemotherapy causes nerve damage, leading to pain, tingling, or numbness, usually in the hands or feet. TENS is a process where small electrical currents are applied to the skin, which might help relieve these symptoms. The trial is designed to see if TENS can be a useful and practical treatment for reducing CIPN symptoms.
- Participants will use TENS at home for 1 hour every day over 14 days.
- Participants must have stage I-III breast cancer and be receiving chemotherapy with specific drugs (paclitaxel or docetaxel).
- Women who can become pregnant must use birth control during the study.
Participants should be willing to follow the study procedures and attend scheduled visits. There are specific conditions that might exclude someone from participating, like having a history of epilepsy or having an implanted electronic device.